{"actionType":"HYDROLYTIC ENZYME","mechanismOfAction":"Triglyceride hydrolytic enzyme","chemblIds":["CHEMBL2108304"],"references":[{"source":"EMA","ids":["https://www.ema.europa.eu/en/documents/product-information/glybera-epar-product-information_en.pdf"],"urls":["https://www.ema.europa.eu/en/documents/product-information/glybera-epar-product-information_en.pdf"]},{"source":"PubMed","ids":["25559420"],"urls":["http://europepmc.org/abstract/MED/25559420"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA inhibitor","chemblIds":["CHEMBL1455"],"references":[{"source":"DailyMed","ids":["setid=8456a8db-a7f6-4bc0-86be-e9c8c374140b"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8456a8db-a7f6-4bc0-86be-e9c8c374140b"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Angiotensin-converting enzyme inhibitor","chemblIds":["CHEMBL419213","CHEMBL1237"],"targetName":"Angiotensin-converting enzyme","targetType":"single protein","targets":["ENSG00000159640"],"references":[{"source":"FDA","ids":["label/2016/019777s074lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019777s074lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"MAP kinase p38 alpha inhibitor","chemblIds":["CHEMBL514201"],"targetName":"MAP kinase p38 alpha","targetType":"single protein","targets":["ENSG00000112062"],"references":[{"source":"PubMed","ids":["19195885","19950901","21659629"],"urls":["http://europepmc.org/abstract/MED/19195885","http://europepmc.org/abstract/MED/19950901","http://europepmc.org/abstract/MED/21659629"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Beta-2 adrenergic receptor agonist","chemblIds":["CHEMBL32800"],"targetName":"Beta-2 adrenergic receptor","targetType":"single protein","targets":["ENSG00000169252"],"references":[{"source":"PubMed","ids":["25726162","27657826","28338133","2991865"],"urls":["http://europepmc.org/abstract/MED/25726162","http://europepmc.org/abstract/MED/27657826","http://europepmc.org/abstract/MED/28338133","http://europepmc.org/abstract/MED/2991865"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase Aurora-A inhibitor","chemblIds":["CHEMBL1980391"],"targetName":"Serine/threonine-protein kinase Aurora-A","targetType":"single protein","targets":["ENSG00000087586"],"references":[{"source":"PubMed","ids":["21553286","24900658","21553286","24900658","21553286","24900658","21553286","24900658","21553286","24900658","21553286","24900658","21553286","24900658"],"urls":["http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Poly [ADP-ribose] polymerase 2 inhibitor","chemblIds":["CHEMBL4112930"],"targetName":"Poly [ADP-ribose] polymerase 2","targetType":"single protein","targets":["ENSG00000129484"],"references":[{"source":"PubMed","ids":["32652442","33264017","32652442","33264017"],"urls":["http://europepmc.org/abstract/MED/32652442","http://europepmc.org/abstract/MED/33264017","http://europepmc.org/abstract/MED/32652442","http://europepmc.org/abstract/MED/33264017"]}]}
{"actionType":"PARTIAL AGONIST","mechanismOfAction":"Beta-1 adrenergic receptor partial agonist","chemblIds":["CHEMBL500"],"targetName":"Beta-1 adrenergic receptor","targetType":"single protein","targets":["ENSG00000043591"],"references":[{"source":"DailyMed","ids":["setid=07fe9cc3-1ef2-420c-b45d-7f1e894b6ef9","setid=07fe9cc3-1ef2-420c-b45d-7f1e894b6ef9"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07fe9cc3-1ef2-420c-b45d-7f1e894b6ef9","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07fe9cc3-1ef2-420c-b45d-7f1e894b6ef9"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Peroxisome proliferator-activated receptor gamma agonist","chemblIds":["CHEMBL519504"],"targetName":"Peroxisome proliferator-activated receptor gamma","targetType":"single protein","targets":["ENSG00000132170"],"references":[{"source":"PubMed","ids":["1438286","1486069"],"urls":["http://europepmc.org/abstract/MED/1438286","http://europepmc.org/abstract/MED/1486069"]},{"source":"Wikipedia","ids":["Aleglitazar","Aleglitazar"],"urls":["http://en.wikipedia.org/wiki/Aleglitazar","http://en.wikipedia.org/wiki/Aleglitazar"]}]}
{"actionType":"CROSS-LINKING AGENT","mechanismOfAction":"High affinity immunoglobulin gamma Fc receptor I cross-linking agent","chemblIds":["CHEMBL2109391"],"targetName":"High affinity immunoglobulin gamma Fc receptor I","targetType":"single protein","targets":["ENSG00000150337"],"references":[{"source":"PubMed","ids":["17602224","17602224"],"urls":["http://europepmc.org/abstract/MED/17602224","http://europepmc.org/abstract/MED/17602224"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Pancreatic lipase inhibitor","chemblIds":["CHEMBL175247"],"targetName":"Pancreatic lipase","targetType":"single protein","targets":["ENSG00000175535"],"references":[{"source":"DailyMed","ids":["setid=5bbdc95b-82a1-4ba5-8185-6504ff68cc06#nlm34090-1","setid=5bbdc95b-82a1-4ba5-8185-6504ff68cc06#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5bbdc95b-82a1-4ba5-8185-6504ff68cc06#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5bbdc95b-82a1-4ba5-8185-6504ff68cc06#nlm34090-1"]}]}
{"actionType":"ANTISENSE INHIBITOR","mechanismOfAction":"Major intermediate early region 2 mRNA antisense inhibitor","chemblIds":["CHEMBL1201512"],"references":[{"source":"FDA","ids":["label/1998/20961lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20961lbl.pdf"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Insulin receptor agonist","chemblIds":["CHEMBL1201644"],"targetName":"Insulin receptor","targetType":"single protein","targets":["ENSG00000171105"],"references":[{"source":"FDA","ids":["label/2015/022472s006s008lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Carbonic anhydrase IX binding agent","chemblIds":["CHEMBL3707280"],"targetName":"Carbonic anhydrase IX","targetType":"single protein","targets":["ENSG00000107159"],"references":[]}
{"actionType":"INHIBITOR","mechanismOfAction":"Dihydroorotate dehydrogenase inhibitor","chemblIds":["CHEMBL1956285"],"targetName":"Dihydroorotate dehydrogenase","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["26180101"],"urls":["https://pubmed.ncbi.nlm.nih.gov/26180101/"]}]}
{"actionType":"AGONIST","mechanismOfAction":"GABA-A receptor; anion channel agonist","chemblIds":["CHEMBL4094894"],"targetName":"GABA-A receptor; anion channel","targetType":"protein complex group","targets":["ENSG00000022355","ENSG00000145864","ENSG00000113327","ENSG00000166206","ENSG00000109158","ENSG00000182256","ENSG00000268089","ENSG00000011677","ENSG00000094755","ENSG00000187730","ENSG00000163285","ENSG00000163288","ENSG00000102287","ENSG00000151834","ENSG00000186297","ENSG00000145863"],"references":[{"source":"Other","ids":["https://haisco-usa.com/r-%26-d"],"urls":["https://haisco-usa.com/r-%26-d"]},{"source":"PubMed","ids":["32415708"],"urls":["http://europepmc.org/abstract/MED/32415708"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"T cell surface glycoprotein CD3 inhibitor","chemblIds":["CHEMBL1201608"],"targetName":"T cell surface glycoprotein CD3","targetType":"protein complex","targets":["ENSG00000198851","ENSG00000160654","ENSG00000167286"],"references":[{"source":"DailyMed","ids":["setid=2a1f1c18-fa95-45e6-bd00-ac53c73f4747"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a1f1c18-fa95-45e6-bd00-ac53c73f4747"]},{"source":"PubMed","ids":["15136729"],"urls":["http://europepmc.org/abstract/MED/15136729"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Glucagon-like peptide 1 receptor agonist","chemblIds":["CHEMBL4297839"],"targetName":"Glucagon-like peptide 1 receptor","targetType":"single protein","targets":["ENSG00000112164"],"references":[{"source":"PubMed","ids":["33325008","33325008"],"urls":["https://pubmed.ncbi.nlm.nih.gov/33325008/","https://pubmed.ncbi.nlm.nih.gov/33325008/"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Androgen Receptor agonist","chemblIds":["CHEMBL1418176"],"targetName":"Androgen Receptor","targetType":"single protein","targets":["ENSG00000169083"],"references":[{"source":"ISBN","ids":["9781118106051"],"urls":["http://www.isbnsearch.org/isbn/9781118106051"]},{"source":"PubMed","ids":["13786997","13824087","9593936"],"urls":["http://europepmc.org/abstract/MED/13786997","http://europepmc.org/abstract/MED/13824087","http://europepmc.org/abstract/MED/9593936"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"ALK tyrosine kinase receptor inhibitor","chemblIds":["CHEMBL3286830"],"targetName":"ALK tyrosine kinase receptor","targetType":"single protein","targets":["ENSG00000171094"],"references":[{"source":"FDA","ids":["label/2018/210868s000lbl.pdf","label/2018/210868s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase receptor RET inhibitor","chemblIds":["CHEMBL2029988"],"targetName":"Tyrosine-protein kinase receptor RET","targetType":"single protein","targets":["ENSG00000165731"],"references":[{"source":"Other","ids":["http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf","http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf","http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf"],"urls":["http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf","http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf","http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Neurokinin 1 receptor antagonist","chemblIds":["CHEMBL522302"],"targetName":"Neurokinin 1 receptor","targetType":"single protein","targets":["ENSG00000115353"],"references":[{"source":"PubMed","ids":["8876035"],"urls":["http://europepmc.org/abstract/MED/8876035"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Thymidine phosphorylase inhibitor","chemblIds":["CHEMBL65375","CHEMBL235668"],"targetName":"Thymidine phosphorylase","targetType":"single protein","targets":["ENSG00000025708"],"references":[{"source":"DailyMed","ids":["setid=f5beed22-d71d-4c0d-8dca-2c7317d65d85"],"urls":["http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5beed22-d71d-4c0d-8dca-2c7317d65d85"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Kappa opioid receptor antagonist","chemblIds":["CHEMBL1921847"],"targetName":"Kappa opioid receptor","targetType":"single protein","targets":["ENSG00000082556"],"references":[{"source":"PubMed","ids":["24071566","26044637"],"urls":["http://europepmc.org/abstract/MED/24071566","http://europepmc.org/abstract/MED/26044637"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Heat-stable enterotoxin receptor agonist","chemblIds":["CHEMBL3301675"],"targetName":"Heat-stable enterotoxin receptor","targetType":"single protein","targets":["ENSG00000070019"],"references":[{"source":"Expert","ids":["LINACLOTIDE"],"urls":["http://chembl.blogspot.co.uk/search?q=LINACLOTIDE"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA gyrase inhibitor","chemblIds":["CHEMBL3183453","CHEMBL36506"],"targetName":"DNA gyrase","targetType":"protein complex","targets":[],"references":[{"source":"PubMed","ids":["10093705"],"urls":["http://europepmc.org/abstract/MED/10093705"]},{"source":"Wikipedia","ids":["Novobiocin"],"urls":["http://en.wikipedia.org/wiki/Novobiocin"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase receptor FLT3 inhibitor","chemblIds":["CHEMBL3301603","CHEMBL3301622"],"targetName":"Tyrosine-protein kinase receptor FLT3","targetType":"single protein","targets":["ENSG00000122025"],"references":[{"source":"FDA","ids":["label/2018/211349s000lbl.pdf","label/2018/211349s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211349s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211349s000lbl.pdf"]},{"source":"Other","ids":["http://meetinglibrary.asco.org/content/131170-144","http://meetinglibrary.asco.org/content/131170-144"],"urls":["http://meetinglibrary.asco.org/content/131170-144","http://meetinglibrary.asco.org/content/131170-144"]},{"source":"PubMed","ids":["26555154","28516360","26555154","28516360"],"urls":["http://europepmc.org/abstract/MED/26555154","http://europepmc.org/abstract/MED/28516360","http://europepmc.org/abstract/MED/26555154","http://europepmc.org/abstract/MED/28516360"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"HERG blocker","chemblIds":["CHEMBL1700","CHEMBL471"],"targetName":"HERG","targetType":"single protein","targets":["ENSG00000055118"],"references":[{"source":"Wikipedia","ids":["Sotalol","Sotalol","Sotalol"],"urls":["http://en.wikipedia.org/wiki/Sotalol","http://en.wikipedia.org/wiki/Sotalol","http://en.wikipedia.org/wiki/Sotalol"]},{"source":"DailyMed","ids":["setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98"]}]}
